Calypte Biomedical Corporation (CBMC.OB) Enters into $8.0 Million Common Stock Purchase Agreement with Fusion Capital
Calypte Biomedical Corporation (CBMC.OB), a developer, manufacturer and marketer of HIV diagnostic tests, announced that the company has entered into…